The endocannabinoid system in cancer-potential therapeutic target?

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 18249558)

Published in Semin Cancer Biol on December 14, 2007

Authors

Jenny Flygare1, Birgitta Sander

Author Affiliations

1: Department of Laboratory Medicine, Divison of Pathology, F46, Karolinska Institutet and Karolinska University Hospital Huddinge, SE 141 86 Stockholm, Sweden.

Articles citing this

Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem (2009) 1.91

Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology (2015) 1.48

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2. Br J Cancer (2009) 1.03

WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells. Cell Death Dis (2011) 0.99

A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res (Phila) (2009) 0.97

GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Br J Pharmacol (2010) 0.95

Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs. Anticancer Agents Med Chem (2012) 0.92

Monoacylglycerol lipase - a target for drug development? Br J Pharmacol (2012) 0.91

Cannabidiol inhibits angiogenesis by multiple mechanisms. Br J Pharmacol (2012) 0.89

Cannabinoids attenuate cancer pain and proliferation in a mouse model. Neurosci Lett (2010) 0.88

Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells. Prostaglandins Other Lipid Mediat (2010) 0.87

Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features. Oncoscience (2014) 0.87

The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells. Mol Cancer Ther (2013) 0.82

Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma. J Histochem Cytochem (2010) 0.81

Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis. Int J Biol Sci (2014) 0.80

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. J Neuroimmune Pharmacol (2015) 0.79

Association of marijuana smoking with oropharyngeal and oral tongue cancers: pooled analysis from the INHANCE consortium. Cancer Epidemiol Biomarkers Prev (2013) 0.78

Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption. Mol Carcinog (2015) 0.76

Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling. PeerJ (2015) 0.76

Roles of Eicosanoids in Prostate Cancer. Future Lipidol (2008) 0.75

18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study. EJNMMI Res (2013) 0.75

Articles by these authors

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients. Proc Natl Acad Sci U S A (2007) 2.39

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol (2007) 2.35

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections. Arthritis Rheum (2011) 2.06

Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists. Blood (2014) 1.58

Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant (2011) 1.54

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. Blood (2011) 1.51

Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood (2011) 1.49

The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol (2008) 1.47

Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res (2012) 1.24

Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood (2012) 1.23

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res (2010) 1.21

CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clin Cancer Res (2007) 1.16

Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic Biol Med (2007) 1.09

Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma. PLoS One (2010) 1.08

Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma. Mol Pharmacol (2006) 1.04

Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood (2003) 1.00

T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab. Clin Cancer Res (2011) 0.95

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis. Med Oncol (2008) 0.95

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. FEBS Lett (2005) 0.94

The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas. Semin Cancer Biol (2011) 0.91

A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus. Am J Clin Pathol (2008) 0.90

Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism. Mol Cancer Res (2009) 0.90

Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. Int J Cancer (2008) 0.89

High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes. BMC Immunol (2009) 0.88

Germline CDKN2A mutations are rare in child and adolescent cutaneous melanoma. Melanoma Res (2004) 0.88

Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma. Leuk Lymphoma (2014) 0.86

High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival. Genes Chromosomes Cancer (2011) 0.86

Maintenance of remission with cyclosporine in paediatric patients with Kimura's disease - two case reports. Acta Paediatr (2011) 0.83

Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times. Br J Haematol (2011) 0.82

Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. Am J Hematol (2012) 0.81

Increased risk of malignant melanoma in patients with systemic mastocytosis? Acta Derm Venereol (2014) 0.81

Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells. Stem Cells Dev (2012) 0.80

SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression. Sci Rep (2013) 0.79

Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia. PLoS One (2012) 0.78

Expression of PTEN and SHP1, investigated from tissue microarrays in pediatric acute lymphoblastic, leukemia. Pediatr Hematol Oncol (2009) 0.78

IL-8 and tumor necrosis factor alpha in heart valves from patients with infective endocarditis. Scand J Infect Dis (2002) 0.77

Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy. Leuk Lymphoma (2013) 0.77

Posttransplant lymphoma--a single-center experience of 500 liver transplantations. Med Oncol (2004) 0.76

Cannabinoid receptors in mantle cell lymphoma. Cell Cycle (2015) 0.75

The significance of diagnosing associated clonal mast cell diseases in patients with venom-induced anaphylaxis and the role of bone marrow investigation. Clin Transl Allergy (2013) 0.75

Acute respiratory failure in 3 children with juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol (2011) 0.75

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus. Acta Derm Venereol (2016) 0.75

[Mastocytosis--a disease with many faces. Investigation and treatment should be performed in consultation with Karolinska University Hospital]. Lakartidningen (2008) 0.75

Elevated p53 protein expression; a predictor of relapse in rare chronic myeloid malignancies in children? Pediatr Hematol Oncol (2014) 0.75

Myelodysplastic features and symptoms mimicking cystic fibrosis in a child with an intracellular vitamin B 12 deficiency. Pediatr Blood Cancer (2007) 0.75

Expression of VEGF and VEGF receptors in childhood precursor B-cell acute lymphoblastic leukemia evaluated by immunohistochemistry. J Pediatr Hematol Oncol (2009) 0.75